Advanced Filters
noise
Found 65,447 clinical trials
L Ling-Jun Li, MD, PhD

Studying Phenotypes of Gestational Diabetes Mellitus in an Asian Pregnant Cohort

Gestational diabetes mellitus (GDM) is a transient hyperglycemic condition identified during pregnancy in women without a history of chronic diabetes. Evidence indicates that GDM can lead to various adverse health outcomes, including preterm birth, progression to pre-diabetes, and type 2 diabetes after delivery in mothers. Notably, GDM is becoming increasingly …

21 - 45 years of age Female Phase N/A
N Nghiem Xuan Huynh, MD, Specialist

Iron Status of Non-anemic Pregnant Women in First Trimester

This cross-sectional study aims to establish reference intervals for iron biomarkers-including serum iron, ferritin, total iron-binding capacity (TIBC), and transferrin saturation (TSAT)-in healthy pregnant women during the first trimester. Additionally, the study will investigate the current prevalence of non-anemic iron deficiency (NAID) in this population. By applying strict inclusion and …

18 - 45 years of age Female Phase N/A
J Jun Xiao, Dr

Bidirectional Cohort Study of Nanfang Spondyloarthritis

Spondyloarthritis(SpA) patients attending Nanfang Hospital of Southern Medical University will generate a large number of clinical condition scales, laboratory indicators, imaging data such as X-rays or MRIs in the course of multiple standardized follow-up visits, as well as medical specimens from some of the patients who undergo surgical treatments. The …

10 - 59 years of age All Phase N/A
A Amanda Strickland

SportsPro: Post-Market Clinical Follow Up Study

Retrospective, multi-center, chart review (only to include data that is part of the surgeons' standard practice)

18 years of age All Phase N/A
A Andreea Valdman, MD

Multi-modal Quantitative Imaging of the Skin

This clinical trial is about evaluating the suitability of multi-modal imaging technology, which covers virtually the entire body, to evaluate the possibility of screening and early detection of disease.

18 years of age All Phase N/A
I Ivonne Turner

Vitaccess Real MG Registry

Vitaccess Real MG (VRMG) is a patient registry designed to capture longitudinal observational data on myasthenia gravis (MG), its treatment, and impact on symptoms, daily activities, and quality of life (QoL). The duration of the registry is 10 years from launch, and approximately 600 patients will be recruited in the …

18 years of age All Phase N/A
L Lei Xu, MD

Accelerated Biological Aging is Associated With Increased Risk of T2DM in the MASLD Population

The association between biological aging and type 2 diabetes mellitus (T2DM) incidence in individuals with and without metabolic dysfunction-associated steatotic liver disease (MASLD) remains unclear.We assessed biological age by calculating phenotypic age (PhenoAge), Klemera-Doubal method (KDMAge), and homeostatic dysregulation (HDAge). To examine the association of biological ageing with the risk …

20 - 90 years of age All Phase N/A
W Won Jung Ha, Ph.D

Safety and Efficacy of Integrative Korean Medicine Treatment for Elderly After Traffic Accident

The purpose of this study was to analyze the medical records of elderly traffic accident patients hospitalized at 4 branches of Jaseng Korean Medicine Hospital to determine the status of elderly patients and the effectiveness and safety of Korean medicine combination treatment.

65 years of age All Phase N/A
R Ros Eeles

The i4i PRODICT™ Study: Evaluation of the i4i PRODICT™ Test in Different Ethnic Groups (The i4i PRODICT™ Study).

The i4i PRODICT™ study has been developed to investigate the uptake and acceptability of the i4i PRODICT™ test which combines both common and rare genetic changes (genetic variants) into one saliva-based DNA test to estimate a person's future risk of prostate cancer (PrCa) in people of varying ethnicities.

40 - 55 years of age Male Phase N/A
I Ismail Turkbey

Hybrid Intelligence for Trustable Diagnosis and Patient Management of Prostate Cancer (HIT-PIRADS)

The purpose of this study is to develop a new way to diagnose prostate cancer through the use of artificial intelligence. The goal is for this new method to reduce delays in diagnoses and to avoid invasive procedures such as biopsies.

18 - 89 years of age Male Phase N/A

Simplify language using AI